Astria Therapeutics
ATXS
ATXS
33 hedge funds and large institutions have $32.8M invested in Astria Therapeutics in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
49% less capital invested
Capital invested by funds: $63.8M → $32.8M (-$30.9M)
Holders
33
Holding in Top 10
–
Calls
$3.23M
Puts
$310K
Top Buyers
| 1 | +$270K | |
| 2 | +$243K | |
| 3 | +$65K | |
| 4 |
BlackRock
New York
|
+$64.7K |
| 5 |
Millennium Management
New York
|
+$55K |
Top Sellers
| 1 | -$3.66M | |
| 2 | -$2.12M | |
| 3 | -$994K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$475K |
| 5 |
Renaissance Technologies
New York
|
-$404K |